Lemonade's share-price drop after a great second quarter is a wild overreaction. Per its Q2 2026 results, in-force premium rose 32.4% to $1.43 billion and revenue grew 79% to $294 million, the 11th straight quarter of accelerating growth, with over 3.3 million customers. x.com  x.com 

Root looks cheap at about 7x earnings while buying back shares, with proven fully loaded economics. Even after $25.3 million of sales and marketing and $32 million of partner acquisition costs, it earned $25 million of GAAP profit with a 92.1% combined ratio. Lemonade grows much faster and may have more upside if retention and cross-sell deliver, but its case rests on modeled lifetime value and its shareholders keep getting diluted. Root's premium volume is roughly flat to down. x.com  x.com  … Show more

Lemonade's profitability problem outweighs its impressive growth. Revenue rose from $23 million in 2018 to $975 million over the last 12 months, a 65% CAGR, and members nearly tripled since 2021. Yet the capital-light insurtech still guides to negative 2026 EBITDA, below its initial expectations, and after 11 years is not close to positive EBITDA. Management has been less transparent about cutting costs. Solving profitability could make it a home run; Root's management is preferred. x.com  x.com  … Show more

Lemonade could justify a $30-40B valuation by 2030 if it pairs growth with AI-driven margins, though this is a framework, not a price target. Compounding in-force premium 35-40% a year, led by Car and multi-product customers, could reach about $6B and $5.25B revenue; at a 20% EBITDA margin, 6-8x sales means $31.5-42B. In Q2 premium grew 33% and revenue 79% while headcount rose only about 5%. It must still control loss ratios and turn EBITDA consistently positive. x.com 

Lemonade's business thesis has not broken; the stock is falling on normal high-beta behavior, not fundamentals. With beta over two, high short interest and no profits yet, it moves sharply with risk appetite. Co-founder Daniel Schreiber's share sales are normal for a founder with concentrated wealth, though their framing was tone deaf, and stock pay is needed to hire engineers against Google and Meta. Long-term holders should watch in-force premium growth, loss ratio and operating leverage. … Show more

Lemonade will likely fall back below $60 again, as it usually does, because it does not expect to be profitable until late 2027–2028, which keeps the stock volatile for a while. x.com 

Lemonade's AI-powered insurance model has improving fundamentals, with revenue expected to grow from $728M to $2.6B by 2029 and management recently raising 2026 guidance. The chart shows a cup pattern and a reclaim of the 200-day moving average on strong volume, putting it in a Stage 2 uptrend. x.com 

Lemonade can go to $300 over the coming years. x.com 

Lemonade looks good but not good enough after a lofty price and high expectations into earnings, so it needs to get cheaper before it is worth buying. In-force premium grew 32% and revenue 79% as it approaches positive cash flow by the end of 2026; the low $40s or $30s would be the level to buy more. x.com  x.com 

Bowhead Specialty is the quality winner over Lemonade, outperforming it on every metric at a fraction of the size. Both grow at the same year-over-year rate, but Bowhead is more profitable, has 3.57% short interest versus Lemonade's 21%, and is worth slightly under $1B against Lemonade's nearly $6B. Lemonade has fallen to about half its $80 level, a reminder that quality beats influencer-driven meme stocks. x.com